IPNews® – In a San Francisco federal court on Wednesday, Complete Genomics argued that it is not infringing Illumina’s patents that cover technology related to DNA-sequencing kits.
Illumina filed a lawsuit against Complete Genomics in 2010 for allegedly using Illumina’s patented gene probe technology in its testing kits without authorization. Complete Genomics asked U.S. District